3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
40
Triple Negative Breast Neoplasms
16
Carcinoma, Transitional Cell
14
Breast Neoplasms
14
Small Cell Lung Carcinoma
12
Urinary Bladder Neoplasms
11
Melanoma
10
Carcinoma, Hepatocellular
9
Neoplasms
8
Carcinoma, Renal Cell
8
Uterine Cervical Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Colorectal Neoplasms
5
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Stomach Neoplasms
2
Solid Tumors
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Kidney Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
Cisplatin
4
Radiotherapy, Intensity-Modulated
3
Cetuximab
3
Radiation
2
Bupropion
2
sodium thiosulfate
1
pembrolizumab
1
durvalumab
1
Varenicline
1
Tobacco Use Cessation Devices
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Pilocarpine
1
Oral Hygiene
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Immunoglobulin G
1
Gene Expression Profiling
1
Fluorodeoxyglucose F18
1
FPP(RGD)2
1
Early Intervention, Educational
1
Drug Therapy
1
Doxepin
1
Disulfides
1
Counseling
1
Celecoxib
1
Acupuncture Therapy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hypopharyngeal Neoplasms
×
atezolizumab
×
Clear all
No trials found.